The 2023 ESCEO-IOF Herbert Fleisch Medal, awarded by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF), has been presented to Professor Bernard Cortet, Professor of Rheumatology at the Lille Hospital and University Center in Lille, France.
The prestigious Award is named in honour of the late Professor Herbert Fleisch who was an internationally renowned pioneer of the bone and muscle field. It is awarded in recognition of outstanding and ground-breaking achievements in basic bone science or musculoskeletal research. The 2023 Award was presented today during the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2023), taking place from May 4-7, 2023 in Barcelona, Spain.
Professor Jean-Yves Reginster, ESCEO President and Co-Chair of WCO-IOF-ESCEO 2023, stated:
“We are delighted to award this year’s prestigious ESCEO-IOF Medal of Achievement to Professor Bernard Cortet in recognition of his dedication to the field and his many nationally and internationally recognized scientific achievements. The Award also recognizes Professor Cortet’s valued contributions to both the IOF and ESCEO scientific committees. At the national level, his work on behalf of the Osteoporosis Research and Information Group (GRIO) has been of enormous significance for the bone field, including in advancing health professional education, bone health advocacy, and the publication of important clinical recommendations that will benefit medical best practice and patient outcomes throughout France.”
Bernard Cortet is Professor of Rheumatology at the Lille Hospital and University Center (France) since 2003. He is the current head of the Rheumatology Department and of the Neuroscience and Musculoskeletal Unit at the Lille University-Hospital. He is the current president of the Osteoporosis Research and Information Group (GRIO) in France and is the vice-president of the French Society of Rheumatology. He is also deputy director of a research laboratory ULR 4490 (marrow adiposity and bone lab: MABLAB). He is author or co-author of more than 265 publications, primarily in the field of osteoporosis and various aspects of bone fragility, particularly in anorexia nervosa, transplant patients, obese subjects, and after bariatric surgery. On behalf of GRIO he has contributed to the publication of several French management recommendations: corticosteroid-induced osteoporosis (2014), postmenopausal osteoporosis (2018), male osteoporosis (2021), osteoporosis secondary to bariatric surgery (2022) and dietary recommendations in the prevention and treatment of osteoporosis (2022).
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Barcelona 2023)
Held jointly by IOF and ESCEO, the Congress took place in Barcelona, Spain from May 4-7, 2023. WCO-IOF-ESCEO is the world’s largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. For complete information visit www.wco-iof-esceo.org #OsteoCongress
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org @esceo
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as more than 315 patient, medical and research organizations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. www.osteoporosis.foundation @iofbonehealth